Celastrol attenuates pain and cartilage damage via SDF-1/CXCR4 signalling pathway in osteoarthritis rats
Journal of Pharmacy and Pharmacology2017Vol. 70(1), pp. 81–88
Citations Over TimeTop 10% of 2017 papers
Abstract
Celastrol ameliorate OA in vivo as evidenced by the attenuated joint pain and less cartilage damage in OA rats given celastrol treatments, an effect mediated via suppression of the SDF-1/CXCR4 pathway.
Related Papers
- → Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response(2016)202 cited
- → Flow cytometry applications for the analysis of chemokine receptor expression and function(2014)19 cited
- → Chemokine immunobiology in HIV-1 pathogenesis(1999)33 cited
- → Flow Cytometry Detection of Chemokine Receptors for the Identification of Murine Monocyte and Neutrophil Subsets(2015)1 cited
- → Analyse der Expression von Chemokinen und Chemokinrezeptoren in Kopf-Hals-Tumorzellen(2018)